Hi,
moomoo ID:NaN
Log Out
ENGLISH
  • ENGLISH
  • 中文繁体
  • 中文简体
donwloadimg

Download App

Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Moomoo > Quotes > 02137 BRII-B > Detailed Quotes

02137 BRII-B

5.900
+0.120+2.08%
Market Close 09/27 16:08 CCT
High
5.980
Open
5.960
Turnover
23.50M
Low
5.650
Pre Close
5.780
Volume
4.05M
Market Cap
4.27B
P/E(TTM)
Loss
52wk High
48.650
Shares
723.35M
P/E(Static)
Loss
52wk Low
5.410
Float Cap
4.27B
Bid/Ask %
-69.44%
Historical High
52.600
Shs Float
723.35M
Volume Ratio
0.95
Historical Low
5.410
Dividend TTM
--
Div Yield TTM
--
P/B
1.14
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
0.56%
Amplitude
5.71%
Avg Price
5.810
Lot Size
500
Float Cap
4.27B
Bid/Ask %
-69.44%
Historical High
52.600
Shs Float
723.35M
Volume Ratio
0.95
Historical Low
5.410
Dividend TTM
--
P/B
1.14
Dividend LFY
--
Turnover Ratio
0.56%
Amplitude
5.71%
Avg Price
5.810
Lot Size
500
Price Forecast

No Data

News

Comment

Company Overview More
Tengsheng Boyao Biotechnology Co., Ltd. is a biotechnology company headquartered in China and the United States, mainly engaged in infectious disease therapy research and development business. The company's products are used in infectious diseases (such as hepatitis B virus (HBV), human immunodeficiency virus (HIV), multidrug-resistant (MDR) or extensively drug-resistant (XDR) Gram-negative bacteria infections) and other diseases with significant public health burdens, such as central nervous system (CNS) diseases. The company also develops treatments for COVID-19 and others.
CEO: Zhi HONG
Market: Hong Kong motherboard
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...